This module is intended for surgeons interested in recent research highlighting the prognostic value of sentinel node biopsy and new evidence on the benefit of total lymphadenectomy for patient survival. In this 1 hour module you will find: summaries of landmark trials in the field of melanoma, associated published commentaries, and relevant case-based scenarios with response feedback.Learning objectives:
This program was supported by educational grants from Roche and Novartis.
You must have an MDcme.ca account and be logged in to register for this course
Accreditation for this course expires on
Thursday, July 25, 2019